Management of rising prostate-specific antigen after a negative biopsy

Current Urology Reports

Volumn 12, Issue 3, 2011, Pages 197-202

  Levy, David A ^a   Jones, J Stephen ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Biopsy; Extended biopsy; Prostate cancer; Saturation

Indexed keywords

ANTIBIOTIC AGENT; DUTASTERIDE; FINASTERIDE; PLACEBO; PROSTATE SPECIFIC ANTIGEN; STEROID 5ALPHA REDUCTASE INHIBITOR;

ACINAR CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RISK; CELL PROLIFERATION; DIAGNOSTIC ERROR; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REPEAT PROCEDURE; RISK REDUCTION; TREATMENT DURATION; UROLOGIC EXAMINATION;

5-ALPHA REDUCTASE INHIBITORS; BIOPSY, NEEDLE; FALSE NEGATIVE REACTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 79955789900     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-011-0177-1     Document Type: Article

References (47)

1. KK Hodge JE McNeal TA Stamey 1989 Ultrasound guided transrectal core biopsies of the palpably abnormal prostate J Urol 142 66 70 2659826 1:STN:280:DyaL1M3otVSksw%3D%3D (Pubitemid 19184005)
2. KK Hodge JE McNeal MK Terris, et al. 1989 Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate J Urol 142 71 74 2659827 1:STN:280:DyaL1M3otVSksA%3D%3D
3. DW Keetch WJ Catalona DS Smith 1994 Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values J Urol 151 1571 1574 7514690 1:STN:280:DyaK2c3ks1Orug%3D%3D (Pubitemid 24151304)
4. GP Haas NP Delongchamps RF Jones, et al. 2007 Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence J Natl Cancer Inst 99 1484 1489 17895474 10.1093/jnci/djm153
5. IM Thompson DP Ankerst C Chi, et al. 2006 Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 529 534 16622122 10.1093/jnci/djj131 (Pubitemid 43898816)
6. CT Nguyen C Yu AS Moussa, et al. 2010 Performance of the prostate cancer prevention trial risk calculator in a contemporary cohort of men screened for prostate cancer and diagnosed with extended prostate biopsy schemes J Urol 183 529 533 20006887 10.1016/j.juro.2009.10.007
7. YM Hong FC Lai CH Chon, et al. 2004 Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies Urol Oncol 22 7 10 14969796 10.1016/S1078-1439(03)00147-9 (Pubitemid 38542705)
8. Baccala AA, Moussa AS, Hernandez AV, et al. Risk factors and predictors of prostate cancer in men with negative repeat saturation biopsy. UroToday International Journal. 2010, in press.
9. L Schoenfield JS Jones CD Zippe, et al. 2007 The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer BJU Int 99 770 774 17233800 10.1111/j.1464-410X.2006.06728.x 1:CAS:528: DC%2BD2sXlsVygurw%3D (Pubitemid 46439582)
10. R Abouassaly N Tan A Moussa JS Jones 2008 Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies J Urol 180 911 914 18635220 10.1016/j.juro.2008.05.019
11. Wolters T, van der Kwast TH, Vissers CJ, et al. False-negative prostate needle biopsies: frequency, histopathologic features, and follow-up. Am J Surg Pathol. 2010;34:35-43. This article established that histological examination of biopsy material may miss cancer in a real percentage of patients. The implication is that a second pathological opinion might be of value, at least in equivocal cases.
12. GK Lefkowitz GS Sidhu P Torre H Lepor SS Taneja 2001 Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling? Urology 58 999 1003 11744476 10.1016/S0090-4295(01) 01436-4 1:STN:280:DC%2BD3MnpvV2mtg%3D%3D (Pubitemid 34017288)
13. JE McNeal EA Redwine FS Freiha, et al. 1988 Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread Am J Surg Pathol 12 897 906 3202246 10.1097/00000478-198812000-00001 1:STN:280:DyaL1M%2FnsV2rtw%3D%3D (Pubitemid 19011040)
14. M Bazinet PI Karakiewicz AG Aprikian, et al. 1996 Value of systematic transition zone biopsies in the early detection of prostate cancer J Urol 155 605 606 8558670 10.1016/S0022-5347(01)66463-2 1:STN:280:DyaK287jsVejtQ%3D%3D (Pubitemid 26023553)
15. MK Terris TQ Pham MM Issa, et al. 1997 Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated J Urol 157 204 206 8976251 10.1016/S0022-5347(01)65325-4 1:STN:280:DyaK2s7jtVCrug%3D%3D (Pubitemid 26414958)
16. JI Epstein PC Walsh J Sauvageot, et al. 1997 Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer J Urol 158 1886 1890 9334623 10.1016/S0022-5347(01)64159-4 1:STN:280:DyaK2svnsFSquw%3D%3D (Pubitemid 27433172)
17. AR Patel JS Jones J Rabets, et al. 2004 Parasagittal biopsies add minimal information in repeat saturation prostate biopsy Urology 63 87 89 14751355 10.1016/j.urology.2003.08.040 (Pubitemid 38147556)
18. R Takashima S Egawa S Kuwao, et al. 2002 Anterior distribution of Stage T1c nonpalpable tumors in radical prostatectomy specimens Urology 59 692 697 11992842 10.1016/S0090-4295(02)01525-X (Pubitemid 34461979)
19. SR Bott MP Young MJ Kellett, et al. 2002 Anterior prostate cancer: is it more difficult to diagnose? BJU Int 89 886 889 12010233 10.1046/j.1464-410X. 2002.02796.x 1:STN:280:DC%2BD383ntV2isA%3D%3D (Pubitemid 34535421)
20. Bouyé S, Potiron E, Puech P, et al. Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology. Prostate. 2009;69:105-113. This article demonstrated that anterior cancers may be missed by biopsy but detected by MRI.
21. JL Wright WJ Ellis 2006 Improved prostate cancer detection with anterior apical prostate biopsies Urol Oncol 24 492 495 17138129 10.1016/j.urolonc.2006. 03.003 (Pubitemid 44810011)
22. Moussa AS, Meshref A, Schoenfield L, et al. Importance of additional "extreme" anterior apical needle biopsies in the initial detection of prostate cancer. Urology, accepted for publication. 2010.
23. TA Stamey 1995 Making the most out of six systematic sextant biopsies Urology 45 2 12 7817477 10.1016/S0090-4295(95)96168-2 1:STN:280: DyaK2M7hslahsw%3D%3D
24. DW Keetch WJ Catalona DS Smith 1994 Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values J Urol 151 1571 1574 7514690 1:STN:280:DyaK2c3ks1Orug%3D%3D (Pubitemid 24151304)
25. RJ Babaian A Toi K Kamoi, et al. 2000 A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy J Urol 163 152 157 10604335 10.1016/S0022-5347(05)67993-1 1:STN:280:DC%2BD3c%2Fmslyhtg%3D%3D
26. LA Eskew RL Bare DL McCullough 1997 Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate J Urol 157 199 202 8976250 10.1016/S0022-5347(01)65322-9 1:STN:280:DyaK2s7jtVCrtQ%3D%3D
27. JC Presti Jr JJ Chang V Bhargava, et al. 2000 The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial J Urol 163 163 166 10604337 10.1016/S0022-5347(05) 67995-5
28. JL Gore SF Shariat BJ Miles, et al. 2001 Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer J Urol 165 1554 1559 11342916 10.1016/S0022-5347(05)66347-1 1:STN:280:DC%2BD3M3ovVOitw%3D%3D (Pubitemid 32410237)
29. JC Presti Jr GJ O'Dowd MC Miller, et al. 2003 Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study J Urol 169 125 129 12478119 10.1016/S0022-5347(05)64051-7 (Pubitemid 35461569)
30. AP Berger C Gozzi H Steiner, et al. 2004 Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores J Urol 171 1478 1480 15017202 10.1097/01.ju.0000116449.01186.f7 (Pubitemid 38365399)
31. Ching CB, Moussa AS, Li J, et al. Does transrectal ultrasound probe really matter? End-fire versus side-fire: prostate cancer detection rates. J Urol. 2009, 181:2077-2082. This article showed that end-fire probes can traverse the gland and identify anterior or apical tumors more accurately than more common side-fire probes.
32. PI Karakiewicz M Bazinet AG Aprikian, et al. 1997 Outcome of sextant biopsy according to gland volume Urology 49 55 59 9000186 10.1016/S0090-4295(96) 00360-3 1:STN:280:DyaK2s7lt1KjsQ%3D%3D (Pubitemid 27043098)
33. B Djavan AR Zlotta M Remzi, et al. 1999 Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection? Urology 54 846 852 10565745 10.1016/S0090-4295(99)00329-5 1:STN:280:DC%2BD3c%2FivFCktw%3D%3D (Pubitemid 29505584)
34. PG Borboroglu SW Comer RH Riffenburgh, et al. 2000 Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies J Urol 163 158 162 10604336 10.1016/S0022-5347(05)67994-3 1:STN:280:DC%2BD3c%2Fmslyhtw%3D%3D
35. CS Stewart BC Leibovich AL Weaver, et al. 2001 Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies J Urol 166 86 91 11435830 10.1016/S0022-5347(05)66083-1 1:STN:280:DC%2BD3MznslGhsg%3D%3D (Pubitemid 32565349)
36. JS Jones A Patel L Schoenfield, et al. 2006 Saturation technique does not improve cancer detection as an initial prostate biopsy strategy J Urol 175 485 488 16406977 10.1016/S0022-5347(05)00211-9 (Pubitemid 43067334)
37. JI Epstein H Sanderson HB Carter DO Scharfstein 2005 Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy Urology 66 356 360 16040085 10.1016/j.urology.2005.03.002 (Pubitemid 41138097)
38. SR Bott A Henderson JE Halls, et al. 2006 Extensive transperineal template biopsies of prostate: modified technique and results Urology 68 1037 1041 17095067 10.1016/j.urology.2006.05.033 (Pubitemid 44750129)
39. T Satoh K Matsumoto T Fujita, et al. 2005 Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy Urology 66 114 118 15992910 10.1016/j.urology.2005.01.051 (Pubitemid 41002198)
40. BJ Moran MH Braccioforte DJ Conterato 2006 Re-biopsy of the prostate using a stereotactic transperineal technique J Urol 176 4 Pt 1 1376 1381 16952636 10.1016/j.juro.2006.06.030 (Pubitemid 44307216)
41. JC Rabets JS Jones A Patel, et al. 2004 Prostate cancer detection with office based saturation biopsy in a repeat biopsy population J Urol 172 94 97 15201745 10.1097/01.ju.0000132134.10470.75 (Pubitemid 41615046)
42. J Walz M Graefen FK Chun, et al. 2006 High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series Eur Urol 50 498 505 16631303 10.1016/j.eururo.2006.03.026 (Pubitemid 44189057)
43. A de la Taille P Antiphon L Salomon, et al. 2003 Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate Urology 61 1181 1186 12809894 10.1016/S0090-4295(03)00108-0 (Pubitemid 36693999)
44. A Sciarra V Panebianco M Ciccariello, et al. 2010 Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy Clin Cancer Res 16 1875 1883 20197480 10.1158/1078-0432.CCR-09-2195 1:CAS:528: DC%2BC3cXjtFyhur0%3D
45. SM Noworolski DB Vigneron AP Chen J Kurhanewicz 2008 Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues Magn Reson Imaging 26 1071 1080 18508221 10.1016/j.mri.2008.01.033
46. P Puech N Betrouni N Makni, et al. 2009 Computer-assisted diagnosis of prostate cancer using DCE-MRI data: design, implementation and preliminary results Int J Comput Assist Radiol Surg 4 1 10 20033597 10.1007/s11548-008-0261- 2
47. GL Andriole DG Bostwick OW Brawley, et al. 2010 Effect of dutasteride on the risk of prostate cancer N Engl J Med 362 1192 1202 20357281 10.1056/NEJMoa0908127 1:CAS:528:DC%2BC3cXkt1Cns7g%3D